| Product Name | Lenvatinib | E7080 | 
|---|---|
| CAS | 417716-92-8 | 
| Formula | C21H19ClN4O4 | 
| MW | 426.85 | 
| Appearance | Off-white to light yellow powder | 
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
| 
                                             There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.  | 
                                    |||||
| Product Name | Lenvatinib | E7080 | 
|---|---|
| CAS | 417716-92-8 | 
| Formula | C21H19ClN4O4 | 
| MW | 426.85 | 
| Appearance | Off-white to light yellow powder | 
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
Lenvatinib is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, less potent against VEGFR1/Flt-1, ~10-fold more selective for VEGFR2/3 against FGFR1, PDGFRα/β in cell-free assays. Lenvatinib (E7080) also inhibits FGFR1-4, PDGFR, Kit (c-Kit), RET (c-RET), and shows potent antitumor activities.